AlphaStocks
6.0
Consider Buy

Arcosa, Inc. (ACA)

As of Sep 20, 2026, Arcosa, Inc. (ACA) scores 6.0/10 on AlphaStocks' five-model composite, #42 of 265 Industrials stocks. At $146, ACA trades 54% above its model fair value of $95.

Industrials / Construction & Engineering

S&P SmallCap 600

$145.82

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#42out of 265 in Industrials

Is Arcosa, Inc. a Good Investment in 2026?

Arcosa, Inc. (ACA) scores 6.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Arcosa, Inc. as Strong (8/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. Arcosa, Inc. currently trades 54% above its estimated fair value of $95. Arcosa, Inc. ranks #42 out of 265 stocks in the Industrials sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E34.3ROE8.0Market Cap7B

Estimated Fair Value

$94.6154% above

Trading above estimated fair value. Rapid eps growth (122%) partially justifies the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

8/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Neutral

Earnings yield 4.1% · ROC 13%

Frequently Asked Questions

Is Arcosa, Inc. (ACA) a good investment?
As of Sep 20, 2026, Arcosa, Inc. (ACA) scores 6.0/10 on AlphaStocks' five-model composite, #42 of 265 Industrials stocks. At $146, ACA trades 54% above its model fair value of $95. That is a middle-of-the-pack score with no strong signal either way.
What is Arcosa, Inc.'s Piotroski F-Score?
Arcosa, Inc.'s Piotroski F-Score status is Strong. The raw score is 8/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ACA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $95, ACA appears overvalued. The stock currently trades 54% above its estimated fair value. Trading above estimated fair value. Rapid eps growth (122%) partially justifies the premium.
How does ACA compare to other Industrials stocks?
Arcosa, Inc. ranks #42 out of 265 stocks in the Industrials sector, placing it in the top 16% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about ACA?
AlphaStocks evaluates ACA using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Neutral; Lynch: Attractive; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 6.0/10.

Similar Stocks

TTEKFIXSTRL

Compare ACA with

ACA vs TTEKACA vs FIXACA vs STRLACA vs PARR

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer